Published adverse event data for both routes provides useful benchmarks for monitoring injection-site outcomes
Boasting domestic manufacturing, ex-Novo Nordisk leadership and a market hungry for cheaper GLP-1s, Toronto start-up Vimy Pharma says it plans to produce a Canadian-made generic of Ozempic (semaglutide) as protections on the blockbuster diabetes/obesity drug unwind in Canada in early 2026
No large-scale human safety trials have been published
Unlike many compounds targeting hormonal pathways, PT-141 works through the central nervous system, specifically activating melanocortin receptors involved in sexual response
Injection supplies: Syringes, needles, alcohol swabs, and sharps containers
The adverse effects of GLP-1RA, such as nausea, constipation, and diarrhea, are thought to be the result of the pharmacological action of GLP-1, but the mechanisms have not been fully elucidated